286 related articles for article (PubMed ID: 19922755)
1. The role of histaminergic H1 and H3 receptors in food intake: a mechanism for atypical antipsychotic-induced weight gain?
Deng C; Weston-Green K; Huang XF
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):1-4. PubMed ID: 19922755
[TBL] [Abstract][Full Text] [Related]
2. Time-dependent effects of olanzapine treatment on the expression of histidine decarboxylase, H1 and H3 receptor in the rat brain: The roles in olanzapine-induced obesity.
He M; Zhang Q; Deng C; Jin T; Song X; Wang H; Huang XF
Psychoneuroendocrinology; 2017 Nov; 85():190-199. PubMed ID: 28886461
[TBL] [Abstract][Full Text] [Related]
3. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.
Kroeze WK; Hufeisen SJ; Popadak BA; Renock SM; Steinberg S; Ernsberger P; Jayathilake K; Meltzer HY; Roth BL
Neuropsychopharmacology; 2003 Mar; 28(3):519-26. PubMed ID: 12629531
[TBL] [Abstract][Full Text] [Related]
4. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
[TBL] [Abstract][Full Text] [Related]
5. Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes.
Silvestre JS; Prous J
Methods Find Exp Clin Pharmacol; 2005 Jun; 27(5):289-304. PubMed ID: 16082416
[TBL] [Abstract][Full Text] [Related]
6. Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications.
Lian J; Huang XF; Pai N; Deng C
Pharmacol Res; 2016 Apr; 106():51-63. PubMed ID: 26892184
[TBL] [Abstract][Full Text] [Related]
7. Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms.
Reynolds GP; Kirk SL
Pharmacol Ther; 2010 Jan; 125(1):169-79. PubMed ID: 19931306
[TBL] [Abstract][Full Text] [Related]
8. Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression.
Han M; Deng C; Burne TH; Newell KA; Huang XF
Psychoneuroendocrinology; 2008 Jun; 33(5):569-80. PubMed ID: 18358632
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of serotonin 5-HT2 receptor in the regulation of feeding behavior through the histaminergic system.
Murotani T; Ishizuka T; Isogawa Y; Karashima M; Yamatodani A
Neuropharmacology; 2011; 61(1-2):228-33. PubMed ID: 21514311
[TBL] [Abstract][Full Text] [Related]
10. Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight.
Malmlöf K; Zaragoza F; Golozoubova V; Refsgaard HH; Cremers T; Raun K; Wulff BS; Johansen PB; Westerink B; Rimvall K
Int J Obes (Lond); 2005 Dec; 29(12):1402-12. PubMed ID: 16151415
[TBL] [Abstract][Full Text] [Related]
11. [Weight gain from atypical neuroleptics--an underreported adverse effect?].
Wetterling T
Fortschr Neurol Psychiatr; 2000 Dec; 68(12):546-56. PubMed ID: 11200858
[TBL] [Abstract][Full Text] [Related]
12. Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways.
Lian J; Huang XF; Pai N; Deng C
Psychoneuroendocrinology; 2014 Oct; 48():77-86. PubMed ID: 24992721
[TBL] [Abstract][Full Text] [Related]
13. The histamine H3 receptor and eating behavior.
Passani MB; Blandina P; Torrealba F
J Pharmacol Exp Ther; 2011 Jan; 336(1):24-9. PubMed ID: 20864503
[TBL] [Abstract][Full Text] [Related]
14. Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model.
Deng C; Lian J; Pai N; Huang XF
J Psychopharmacol; 2012 Sep; 26(9):1271-9. PubMed ID: 22695490
[TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotics and weight gain.
Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):46-58. PubMed ID: 19667655
[TBL] [Abstract][Full Text] [Related]
16. The role of hypothalamic H1 receptor antagonism in antipsychotic-induced weight gain.
He M; Deng C; Huang XF
CNS Drugs; 2013 Jun; 27(6):423-34. PubMed ID: 23640535
[TBL] [Abstract][Full Text] [Related]
17. Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gain.
Tiwari AK; Zhang D; Pouget JG; Zai CC; Chowdhury NI; Brandl EJ; Qin L; Freeman N; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
World J Biol Psychiatry; 2018; 19(sup3):S97-S105. PubMed ID: 27855565
[TBL] [Abstract][Full Text] [Related]
18. Histamine H3-receptor inverse agonists as novel antipsychotics.
Ito C
Cent Nerv Syst Agents Med Chem; 2009 Jun; 9(2):132-6. PubMed ID: 20021346
[TBL] [Abstract][Full Text] [Related]
19. Risperidone-induced weight gain and reduced locomotor activity in juvenile female rats: The role of histaminergic and NPY pathways.
Lian J; De Santis M; He M; Deng C
Pharmacol Res; 2015; 95-96():20-6. PubMed ID: 25782398
[TBL] [Abstract][Full Text] [Related]
20. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
